10x Genomics Inc (TXG)

10x Genomics (TXG) Income Statement


10x Genomics Income Statement

Last quarter (Q4 2022), 10x Genomics's total revenue was $156.23M, an increase of 8.85% from the same quarter last year. In Q4, 10x Genomics's net income was $-17.21M. See 10x Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 516.41M$ 516.41M$ 490.49M$ 298.85M$ 245.89M$ 146.31M
Cost of Revenue
$ 120.39M$ 120.39M$ 74.09M$ 58.47M$ 61.03M$ 28.66M
Gross Profit
$ 396.02M$ 396.02M$ 416.40M$ 240.38M$ 184.86M$ 117.65M
Operating Expense
$ 563.97M$ 563.97M$ 469.31M$ 325.70M$ 213.93M$ 166.05M
Operating Income
$ -167.94M$ -167.94M$ -52.91M$ -85.32M$ -29.07M$ -48.40M
Net Non Operating Interest Income Expense
$ 6.17M$ 6.17M$ -660.00K$ -150.00K$ -274.00K$ -1.39M
Other Income Expense
$ -198.00K$ -198.00K$ -142.00K$ -449.00M$ -1.69M$ -62.61M
Pretax Income
$ -161.97M$ -161.97M$ -53.72M$ -534.48M$ -31.03M$ -112.40M
Tax Provision
$ 4.03M$ 4.03M$ 4.51M$ 8.26M$ 218.00K$ 87.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -166.00M$ -166.00M$ -58.22M$ -542.73M$ -31.25M$ -112.48M
Basic EPS
$ -1.47$ -1.46$ -0.53$ -5.37$ -0.80$ -1.36
Diluted EPS
$ -1.47$ -1.46$ -0.53$ -5.37$ -0.80$ -1.36
Basic Average Shares
$ 455.42M$ 113.86M$ 110.35M$ 101.15M$ 39.09M$ 82.89M
Diluted Average Shares
$ 455.42M$ 113.86M$ 110.35M$ 101.15M$ 39.09M$ 82.89M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 684.35M$ 684.35M$ 543.40M$ 384.17M$ 274.96M$ 194.71M
Net Income From Continuing And Discontinued Operation
$ -166.00M$ -166.00M$ -58.22M$ -542.73M$ -31.25M$ -112.48M
Normalized Income
$ -166.00M$ -166.00M$ -58.70M$ -213.98M$ -30.15M$ -66.96M
Interest Expense
$ 476.00K$ 476.00K$ 866.00K$ 1.68M$ 3.08M$ 2.41M
$ -161.50M$ -161.50M$ -52.85M$ -532.79M$ -27.95M$ -109.99M
$ -128.49M$ -128.49M$ -24.59M$ -513.77M$ -20.89M$ -106.08M
Currency in USD

10x Genomics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis